Category: CovidienSyndicate content

March 2014 Medical device recalls | Medtech regulatory news for the week of Apr. 7, 2014

April 8, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week.

Medical device recalls for March 2014

April 2, 2014 by MassDevice staff

FDA logo

March Summary
Class I recalls: 10
Class II recalls: 183

Z-Medica taps ex-Solta Medical CEO Fanning | Personnel Moves

April 3, 2014 by Brad Perriello

Stephen Fanning, the former CEO of Solta Medical, is Z-Medica's new chief.

Z-Medica taps ex-Solta Medical CEO Fanning

Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.

Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Going global: New AdvaMed chairman Almeida's focus on medtech harmony around the world

April 2, 2014 by Arezu Sarvestani

Covidien president & CEO AdvaMed board chairman Jose Almeida details his focus for his 2-year tenure as the chairman of the board for medtech lobbying group AdvaMed.

Harmony and ethics: New AdvaMed chairman Almeida's commitment to medtech

Incoming AdvaMed chairman Jose Almeida has an international outlook, planning to focus his 2-year leadership tenure on several goals that aim to reconcile initiatives in the U.S. with efforts overseas.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech trends: The most talked about device makers in March 2014

April 2, 2014 by Arezu Sarvestani

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Baxter reveals plans to split pharma, medical products businesses

March 27, 2014 by Brad Perriello

Baxter International says it plans to go the way of rivals Abbott and Covidien in splitting its pharmaceuticals and medical products businesses into separate companies.

Baxter reveals plans to split pharma, medical products businesses

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp